Carr Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Buy
1,126
+3
+0.3% +$812 0.08% 138
2025
Q4
$282K Buy
1,123
+3
+0.3% +$797 0.07% 147
2025
Q3
$322K Buy
1,120
+2
+0.2% +$536 0.09% 140
2025
Q2
$293K Buy
1,118
+4
+0.4% +$974 0.09% 145
2025
Q1
$259K Sell
1,114
-98
-8% -$23.8K 0.09% 150
2024
Q4
$278K Buy
1,212
+4
+0.3% +$918 0.09% 155
2024
Q3
$270K Buy
1,208
+4
+0.3% +$879 0.08% 165
2024
Q2
$245K Buy
1,204
+4
+0.3% +$814 0.08% 168
2024
Q1
$262K Hold
1,200
0.09% 160
2023
Q4
$273K Hold
1,200
0.1% 138
2023
Q3
$252K Sell
1,200
-197
-14% -$41.6K 0.1% 145
2023
Q2
$290K Hold
1,397
0.12% 136
2023
Q1
$275K Hold
1,397
0.12% 133
2022
Q4
$283K Buy
+1,397
New +$273K 0.15% 132

Other funds holding LH

Carr Financial Group's LH Position: Q1 2026 in Review

Carr Financial Group increased its Labcorp (LH) stake by 0.27% in Q1 2026, buying an estimated $812 and bringing the position to 1,126 shares worth $301K. The position accounts for 0.08% of the portfolio, ranked #138.

Carr Financial Group first reported a position in LH in Q4 2022 and has held it in 14 quarters since. The position peaked at $322K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Carr Financial Group held 1,126 shares of Labcorp worth $301K as of Q1 2026.
  • Carr Financial Group bought 3 Labcorp shares in Q1 2026, an estimated $812.
  • Labcorp made up 0.08% of Carr Financial Group's portfolio in Q1 2026, its #138 holding.
  • Carr Financial Group first reported a position in Labcorp in Q4 2022 and has held it in 14 quarters since.
  • Carr Financial Group's Labcorp position peaked at $322K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.